Stay updated with breaking news from Leverage Clinical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SK바이오사이언스가 개발중인 코로나19 백신이 3상 임상시험 계획을 승인받았다. 국내 업체의 코로나19 백신이 개발 막바지 단계인 임상 3상에 진입한 것은 이번이 처음이다. SK바이오사이언스는 이르면 내년 상반기쯤 코로나19 백신을 내보일 계획이다. 식품의약품안전처는 10일 SK바이오사이언스의 코로나19 백신 ‘GBP510’에 대해 3상 임상계획의 안전성과 - 아스트라제네카 AZ 백신,면역,임상 시험,승인,이다,백신 접종,국제,코로나19 백신,SK바이오사이언...
Share this article Share this article ResearchAndMarkets.com's offering. Clinical Trials, the most crucial step in drug discovery has never been in the forefront in adopting new technologies and transforming from the conventional protocols. With the development of AI/ML in the last five years, it has opened up a new horizon for transforming clinical trials. It has been proven that use of AI/ML tools can scan through large volumes of data and provide accurate results within minutes which takes enormous time when performed by humans. Application of analytical tools help identify trends and pa...